• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动员过程对接受自体造血干细胞移植患者心脏功能和大小的早期影响。

Early Impact of Mobilization Process on Cardiac Function and Size in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.

作者信息

Vaitiekiene Audrone, Kulboke Migle, Bieseviciene Monika, Bartnykaite Agne, Kireilis Benas, Rinkuniene Diana, Jankauskas Antanas, Zemaitis Justinas, Gaidamavicius Ignas, Gerbutavicius Rolandas, Vaitiekus Domas, Vaskelyte Jolanta Justina, Sakalyte Gintare

机构信息

Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

Department of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

出版信息

J Clin Med. 2024 Jan 29;13(3):773. doi: 10.3390/jcm13030773.

DOI:10.3390/jcm13030773
PMID:38337467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10856069/
Abstract

The hematopoietic stem cell transplantation (HSCT) process is known to cause cardiac toxicity of different grades. In this paper, we aimed to evaluate the impact of mobilization procedure of hematopoietic stem cells for autologous HSCT process for left and right ventricle sizes and functions. The data of 47 patients undergoing autologous HSCT were analyzed. All patients underwent hematopoietic stem cell mobilization with chemotherapy and filgrastim at 10 µg/kg/d. Echocardiography was performed two times: before enrolling in the transplantation process and after mobilization before the conditioning regimen for transplantation. Changes in left and right ventricle (RV) diameter and systolic and diastolic function of the left ventricle and systolic function of the RV were measured. : A statistically significant difference was observed in the change of right ventricular function (S')-it slightly decreased. Mean S' before mobilization was 13.93 ± 2.85 cm/s, and after mobilization it was 12.19 ± 2.64 cm/s ( = 0.003). No statistically significant change in left ventricular diameter and systolic and diastolic function and RV diameter was observed. : The mobilization procedure in patients undergoing autologous HSCT is associated with reduced RV systolic function. S' could be used as a reliable tool to evaluate early cardiotoxicity in HSCT patients and guide further follow-up.

摘要

已知造血干细胞移植(HSCT)过程会导致不同程度的心脏毒性。在本文中,我们旨在评估自体HSCT过程中造血干细胞动员程序对左右心室大小和功能的影响。分析了47例接受自体HSCT患者的数据。所有患者均采用化疗和10μg/kg/d的非格司亭进行造血干细胞动员。进行了两次超声心动图检查:在进入移植过程之前以及动员后、移植预处理方案之前。测量了左右心室(RV)直径、左心室收缩和舒张功能以及右心室收缩功能的变化。:观察到右心室功能变化(S')有统计学意义的差异——它略有下降。动员前平均S'为13.93±2.85 cm/s,动员后为12.19±2.64 cm/s(P = 0.003)。未观察到左心室直径、收缩和舒张功能以及右心室直径有统计学意义的变化。:接受自体HSCT患者的动员程序与右心室收缩功能降低有关。S'可作为评估HSCT患者早期心脏毒性的可靠工具并指导进一步随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae0/10856069/922ccb6afa2c/jcm-13-00773-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae0/10856069/922ccb6afa2c/jcm-13-00773-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae0/10856069/922ccb6afa2c/jcm-13-00773-g001.jpg

相似文献

1
Early Impact of Mobilization Process on Cardiac Function and Size in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.动员过程对接受自体造血干细胞移植患者心脏功能和大小的早期影响。
J Clin Med. 2024 Jan 29;13(3):773. doi: 10.3390/jcm13030773.
2
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.一项前瞻性、随机、开放标签、非劣效性研究的结果:Tbo- Filgrastim(Granix)与 Filgrastim(Neupogen)联合 Plerixafor 用于多发性骨髓瘤和非霍奇金淋巴瘤患者自体干细胞动员的比较。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2065-2069. doi: 10.1016/j.bbmt.2017.07.023. Epub 2017 Aug 7.
3
Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation.异基因造血干细胞移植后长期存活者的右心功能障碍。
Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001768.
4
T1 Mapping in Cardiovascular Magnetic Resonance-A Marker of Diffuse Myocardial Fibrosis in Patients Undergoing Hematopoietic Stem Cell Transplantation.心血管磁共振成像中的T1映射——造血干细胞移植患者弥漫性心肌纤维化的标志物
J Pers Med. 2024 Apr 13;14(4):412. doi: 10.3390/jpm14040412.
5
Assessment of Myocardial Function in Children before and after Autologous Peripheral Blood Stem Cell Transplantation.自体外周血干细胞移植前后儿童心肌功能的评估
Echocardiography. 2016 Jan;33(1):82-9. doi: 10.1111/echo.12988. Epub 2015 Jun 8.
6
Right Ventricle before and after Atrial Septal Defect Device Closure.房间隔缺损封堵器闭合前后的右心室
Echocardiography. 2016 Sep;33(9):1381-8. doi: 10.1111/echo.13250. Epub 2016 Apr 24.
7
Hypertrophy of the right ventricle by pulmonary artery banding in rats: a study of structural, functional, and transcriptomics alterations in the right and left ventricles.大鼠肺动脉环扎致右心室肥厚:左右心室结构、功能及转录组学改变的研究
Front Physiol. 2023 Jul 27;14:1129333. doi: 10.3389/fphys.2023.1129333. eCollection 2023.
8
Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.接受自体造血干细胞移植的多发性骨髓瘤患者中高剂量环磷酰胺的心脏毒性。
Int J Hematol. 2007 Jun;85(5):408-14. doi: 10.1532/IJH97.E0620.
9
Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.
Bone Marrow Transplant. 2007 Jul;40(1):47-53. doi: 10.1038/sj.bmt.1705698. Epub 2007 May 7.
10
Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.对于接受自体外周血干细胞移植的患者,低剂量来格司亭在外周血干细胞动员和移植方面与标准剂量非格司亭同样有效:一项随机研究
Am J Hematol. 2008 Aug;83(8):644-8. doi: 10.1002/ajh.21206.

引用本文的文献

1
T1 Mapping in Cardiovascular Magnetic Resonance-A Marker of Diffuse Myocardial Fibrosis in Patients Undergoing Hematopoietic Stem Cell Transplantation.心血管磁共振成像中的T1映射——造血干细胞移植患者弥漫性心肌纤维化的标志物
J Pers Med. 2024 Apr 13;14(4):412. doi: 10.3390/jpm14040412.

本文引用的文献

1
Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.基于蒽环类化疗的乳腺癌患者中,整体纵向应变和 NT-proBNP 对心脏毒性早期发展的预后影响。
Medicina (Kaunas). 2023 May 15;59(5):953. doi: 10.3390/medicina59050953.
2
Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics.化疗诱导性心脏毒性:一般机制、预防、治疗的最新进展及新型治疗方法的综述。
Curr Probl Cardiol. 2023 Apr;48(4):101591. doi: 10.1016/j.cpcardiol.2023.101591. Epub 2023 Jan 6.
3
Cardiovascular complications among hematopoietic cell transplantation survivors - the role of cardiomarkers.
造血细胞移植幸存者中的心血管并发症——心脏标志物的作用
Klin Onkol. 2022 Fall;35(6):454-460. doi: 10.48095/ccko2022454.
4
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会(ESC)与欧洲血液学协会(EHA)、欧洲治疗放射学与肿瘤学协会(ESTRO)以及国际心脏肿瘤学会(IC-OS)合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
5
Right ventricular function across the spectrum of health and disease.右心室功能在健康和疾病中的表现。
Heart. 2023 Feb 14;109(5):349-355. doi: 10.1136/heartjnl-2021-320526.
6
Cardiac complications associated with hematopoietic stem-cell transplantation.造血干细胞移植相关的心脏并发症。
Bone Marrow Transplant. 2021 Nov;56(11):2637-2643. doi: 10.1038/s41409-021-01427-2. Epub 2021 Aug 11.
7
Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques.亚临床心脏毒性:心肌做功和其他影像学技术的新兴作用。
Curr Probl Cardiol. 2021 Jun;46(6):100818. doi: 10.1016/j.cpcardiol.2021.100818. Epub 2021 Feb 16.
8
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation.造血干细胞移植患者中的儿童和成人的心血管疾病及其管理。
J Thromb Thrombolysis. 2021 May;51(4):854-869. doi: 10.1007/s11239-020-02344-9. Epub 2020 Nov 24.
9
Evaluation of the Cardioprotective Effect of Granulocyte Colony Stimulating Factor in Patients with Carbon Monoxide Poisoning.评价粒细胞集落刺激因子对一氧化碳中毒患者的心脏保护作用。
Protein Pept Lett. 2021;28(5):589-601. doi: 10.2174/0929866527666201022112810.
10
HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity.HFE 基因突变对蒽环类药物化疗引起的亚临床心脏毒性的影响。
Cardiovasc Toxicol. 2021 Jan;21(1):59-66. doi: 10.1007/s12012-020-09595-1. Epub 2020 Aug 3.